29 May 2023 , 10:37 AM
Result date: 30th May, 2023
Recommendation: Buy
Target price: Rs. 5,150
Analysts at IIFL Capital Services expect Apollo Hospitals Enterprise (Apollo) to witness a sequential improvement of 150-200 basis points in patient occupancies. The company’s revenue could grow 19% over the year-ago quarter and decline 1% sequentially.
Apollo’s EBITDA losses for 24/7 are likely to remain flat sequentially at Rs. 1.9 billion. Overall EBITDA could inch up 3% over the year-ago quarter, even as they could dip 5% on a sequential basis.
Profit After Tax (PAT) could grow 69% over the year ago quarter and decline 3% on a sequential basis.
Important management insights to watch out for:
March 2023 estimates |
YoY change |
QoQ change |
|
Revenue (Rs. mn) |
42,317 |
19% |
(1)% |
EBITDA (Rs. mn) |
4,791 |
3% |
(5)% |
EBITDA margin (%) |
11.3% |
(174) bps |
(53) bps |
Profit After Tax (Rs. mn) |
1,523 |
69% |
(3)% |
Source: IIFL Research
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.